Delivery Order HHSN261201000043I-HHSN26100001
Award Date 6/21/10
Potential Completion Date 8/28/13
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rochester, MN 55905, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed price delivery order contract awarded by the National Cancer Institute (NCI) to Mayo Clinic, a large non-profit academic medical center. The $130,403.07 contract supports the NCI's Cancer Genome Atlas (TCGA) program, which is recovering tissue samples and data from various types of cancer. This delivery order falls under a larger indefinite delivery/indefinite quantity (IDIQ) contract, valued at up to $9.9 million, that enables the NCI to procure research and development...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The total ceiling value of the contract is $42,000.00. This contract is part of the NCI's Cancer Genome Atlas Program Tissue Purchase master IDIQ contract. The contract...
- This is a firm-fixed price delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Mayo Clinic, a renowned non-profit academic medical center. The contract is for $1,603.00 and covers pre-clinical pharmacokinetic and pharmacology evaluations of cancer therapeutic agents being developed under the NCI's Experimental Therapeutics program. This work supports the transition of promising cancer treatments from the laboratory to early...
- This is a delivery order contract awarded under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract. The contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, for the recovery of tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program. This work is funded through the American Recovery and Reinvestment Act (ARRA). The contract was...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS), to Yale University. The contract is to support the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various types of cancer, as part of the American Recovery and Reinvestment Act (ARRA). The contract has a ceiling value of $76,875 and a period of performance ending on March 31, 2015. This contract was...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) in the amount of $201,998.50. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase, an indefinite delivery contract. The contract is for the recovery and provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the...
- This federal contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Mayo Clinic. The $10,361,614.72 definitive contract will provide resources for studies of selected agents for preclinical development, supporting the NCI's Experimental Therapeutics program. The contract is a cost-no-fee arrangement without a set-aside designation, reflecting Mayo Clinic's status as a large, renowned non-profit academic medical center with...
- This federal contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Mayo Clinic, a renowned non-profit academic medical center. The $806,712.00 contract is for the provision of "CORE INFRASTRUCTURE SUPPORT" under the "CLINICAL PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH" major program. The contract is a Delivery Order with a Cost No Fee pricing type. Mayo Clinic is supporting the NCI's...
- This is a definitive contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Mayo Clinic, a renowned non-profit academic medical center. The $39,597,204.00 contract is for early-stage therapeutic development with a Phase II emphasis. The contract does not have a set-aside designation. Under this contract, Mayo Clinic will provide research and development services to support preclinical pharmacokinetic and pharmacology evaluations of...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a delivery order contract worth $3,665,424.78 to the Mayo Clinic, a large non-profit academic medical center focused on integrated clinical practice, education, and research. The contract is to provide core infrastructure support for the Cancer Prevention Agent Development Program's Early Phase Clinical Research efforts. This award is not a set-aside contract. Mayo Clinic has extensive...